Key Points
- CME Group CEO Terrence Duffy sold 35,000 shares on May 15 at an average price of $298.51, generating about $10.45 million. After the sale, he still held 55,630 shares, a 38.62% reduction in his direct stake.
- The company’s recent financial results were strong, with quarterly EPS of $3.36 beating estimates of $3.11 and revenue of $1.88 billion topping expectations. Revenue also rose 14.5% year over year.
- CME Group continues to return cash to shareholders, declaring a quarterly dividend of $1.30 per share, payable June 25. That works out to an annualized dividend of $5.20 and a yield of about 1.7%.
CME Group Inc. (NASDAQ:CME - Get Free Report) CEO Terrence Duffy sold 35,000 shares of the business's stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company's stock, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.
CME Group Stock Performance
Shares of CME opened at $305.12 on Tuesday. The business has a 50-day simple moving average of $297.84 and a two-hundred day simple moving average of $288.46. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $257.17 and a 52 week high of $329.16. The stock has a market cap of $110.56 billion, a price-to-earnings ratio of 26.03, a PEG ratio of 3.61 and a beta of 0.23.
CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating analysts' consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion for the quarter, compared to analysts' expectations of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business's quarterly revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.80 EPS. On average, analysts expect that CME Group Inc. will post 12.26 EPS for the current year.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Tuesday, June 9th. CME Group's dividend payout ratio is presently 44.37%.
Hedge Funds Weigh In On CME Group
Several institutional investors have recently bought and sold shares of CME. Whipplewood Advisors LLC boosted its stake in CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock valued at $26,000 after buying an additional 83 shares during the last quarter. Asset Dedication LLC increased its stake in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider's stock worth $26,000 after acquiring an additional 37 shares during the last quarter. FNY Investment Advisers LLC purchased a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group during the 4th quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC bought a new position in shares of CME Group during the 4th quarter valued at approximately $28,000. 87.75% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have recently commented on CME. Erste Group Bank upgraded shares of CME Group from a "hold" rating to a "strong-buy" rating in a research report on Thursday, March 5th. Piper Sandler upped their target price on shares of CME Group from $313.00 to $329.00 and gave the stock an "overweight" rating in a report on Wednesday, April 15th. UBS Group reiterated a "neutral" rating and issued a $310.00 price target on shares of CME Group in a research note on Friday, February 6th. Jefferies Financial Group lowered their price objective on CME Group from $356.00 to $349.00 and set a "buy" rating on the stock in a research report on Thursday, April 9th. Finally, The Goldman Sachs Group dropped their price objective on CME Group from $275.00 to $267.00 and set a "sell" rating for the company in a research note on Thursday, April 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $305.29.
Check Out Our Latest Research Report on CME
CME Group Company Profile
(
Get Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
